Add to favorite
Subscribe to our Newsletters Subscribe to our Newsletters Get Daily Updates RSS

Using a Thrombolytic Drug against Coronavirus Suggested in Russia
29.04.2020 15:16
Using a Thrombolytic Drug against Coronavirus Suggested in Russia

An interagency task force to fight coronavirus at the Siberian Branch of the Russian Academy of Sciences examined the first oral thrombolytic drug, Trombovazim, for use against the effects of COVID. It was reported by Olga Dorokhova, the executive secretary of the task force at the SB RAS.

      She noted that one of the main causes of high mortality of COVID-19 is associated pneumonia caused by coronavirus, and aggravating its course. In the process, a blood clot of fibrin protein is generated in the lungs and blood vessels.

      "That said, there is a new generation fibrinolytic in Russia - Trombovazim. Today, Trombovazim can be considered a target drug," - Olga Dorokhova said.

      Thrombovazim is able to gently inhibit both the formation of fibrin clots and thrombosis in capillaries.

Author: Vera Ivanova

Tags: Russian Medicine COVID    

Next Previous

You might also find interesting:

Comment on our site

RSS   twitter      submit

Russian Millionaires  Bat for Lashes  Russian scientists  Meyerhold Centre  Big Book Award  Voronezh   Jazz  Russian Park  ROSCOSMOS  Russian International  Semyon Chelyuskin  Russian business  Russian Cinema  physics  Yuri Gagarin  Murmansk Region  Spacecrafts  sanctions  Spain  St. Petersburg  Moscow  St. Petersburg gardens  Russia surprises  Mercedes-Benz Fashion Week Russia  Moscow World Fine Art Fair   New Year  Volgograd  Komi Republic  Rusal  Perm Cuisine  Marfino  Arts and Crafts  nanotechnology  Russian economy  Arkhangelsk  Anatoly Kucherena  Yevgeny Roizman  Sergey Shoigu  Astrakhan  Comics  Exhibitions in Moscow  Russian science  Kaluga Region  Soviet Union  Mercedes-Benz Fashion Week   Makhachkala  Theatre Festivals  Sverdlovsk Region  East Meets West Gallery  Russian tourism 

Travel Blogs
Top Traveling Sites